跳至主要内容
临床试验/NCT03821220
NCT03821220Unknown不适用

Improving Physical Activity Levels in the Arabic- Speaking Residents of East Jerusalem With Prediabetes

Clalit Health Services0 个研究点目标入组 375 人开始时间: 2019年2月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
375
主要终点
Physical activity level assessed through average weekly steps

研究概览

简要总结

This three-arm clinical trial aims to improve levels of physical activity among Arabic- speaking residents of East Jerusalem with prediabetes. Levels of daily physical activity (assessed through activity trackers), dietary habits and self-assessed health will be compared between patients that receive only the activity tracker and written information (group A), receive the activity tracker, written information and a personalized physical activity prescription (group B), and those that receive in addition also intensive follow-up with motivational interview by physician assistants and a dietitian (group C)

详细描述

This is a three-arm clinical trial studying the effect of providing activity trackers with intensive motivational interview by trained physician assistants, and dietitian counselling, on the levels of daily physical activity among Arabic- speaking residents of East Jerusalem with prediabetes from Clalit Health Services. In addition, this study will also assess healthy dietary changes, and self assessed health and quality of life.

The study will compare three groups (total 375, each group 125):

Group A - will receive activity trackers and written educational handouts in addition to their usual care.

Group B - will receive all of group A intervention components and also a personalized physical activity prescription.

Group C - will receive all of group B components and also intensive motivational interview support by trained physician assistants (3 sessions), and dietitian support (two sessions).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pre-diabetes patients - Impaired fasting glucose at least twice between 100-125 mg/dL in the two years prior to the study; or HbA1C 5.7%-6.4% twice in the two years prior to the study; or one test of fasting glucose of 100-125 mg/dL, and one test of HbA1C between 5.7%-6.4% in the two years prior to the study.

排除标准

  • Diabetes including a doctor's diagnosis based on a medical file or a recurrence of fasting blood glucose values above 126 mg/dL in the year preceding the study or a glucose value greater than 200 mg/dL in the year prior to the study or HbA1C above 6.5%
  • Treatment with diabetes drugs other than metformin, as prescribed in the medical file with regular or chronic medications
  • Artificial lower limbs or inability to walk normally (eg: stroke with plegia)
  • Chronic obstructive pulmonary disease
  • Known heart disease (with impaired exercise tolerance)
  • Medical conditions:
  • a cardiac event/ Transient ischemic attack in the last year
  • Cerebrovascular attack with residual impairment
  • Surgery that required hospitalization in the last year
  • Injury to lower limbs that prevents regular walking
  • Malignancy excluding skin cancer small cell carcinoma or basal cell carcinoma

研究组 & 干预措施

Group A

Active Comparator

Patients will receive an activity tracker and written information for pre-diabetic, on top of their usual care.

干预措施: Activity tracker plus usual care (Behavioral)

Group B

Active Comparator

Patients will receive an activity tracker, written information for pre-diabetic, and personalized physical activity prescription, on top of their usual care.

干预措施: Activity tracker plus usual care (Behavioral)

Group B

Active Comparator

Patients will receive an activity tracker, written information for pre-diabetic, and personalized physical activity prescription, on top of their usual care.

干预措施: Personalized physical activity prescription (Behavioral)

Group C

Active Comparator

Patients will receive an activity tracker, written information for pre-diabetic, personalized physical activity prescription, three sessions of motivational interview support from trained physician assistants, and two session of dietitian support, on top of their usual care.

干预措施: Motivational Interview support and Dietitian support (Behavioral)

Group C

Active Comparator

Patients will receive an activity tracker, written information for pre-diabetic, personalized physical activity prescription, three sessions of motivational interview support from trained physician assistants, and two session of dietitian support, on top of their usual care.

干预措施: Activity tracker plus usual care (Behavioral)

Group C

Active Comparator

Patients will receive an activity tracker, written information for pre-diabetic, personalized physical activity prescription, three sessions of motivational interview support from trained physician assistants, and two session of dietitian support, on top of their usual care.

干预措施: Personalized physical activity prescription (Behavioral)

结局指标

主要结局

Physical activity level assessed through average weekly steps

时间窗: six months

次要结局

  • Blood pressure(six months)
  • Iron intake 0<mg/day<50(six months)
  • Fasting glucose levels(six months)
  • HbA1C levels(six months)
  • Body Mass Index(six months)
  • Lipid profile(six months)
  • Energy intake 500< kcal/d <6000 kcal/d(Six months)
  • Waist circumference(six months)
  • Fat intake 15 <gram/day<200(six months)
  • Protein intake 10<gram/day<300(six months)
  • Vitamin A intake 20< μg RAE/day<2500(six months)
  • Vitamin C intake 0<mg/day<2500(six months)
  • Folic acid intake 15< μg/day<3000(six months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Amnon Lahad

Director of Medical Quality unit and Chairman department of Family Medicine, Clalit Health Services, Jerusalem district

Clalit Health Services

相似试验